E07.0
Hypersecretion of calcitonin
Clinical Classification Guidelines
Inclusion Terms
- C-cell hyperplasia of thyroid
- Hypersecretion of thyrocalcitonin
Medical Intelligence & Overview
Hypersecretion of calcitonin, also known as thyrocalcitonin, is a rare condition characterized by excessive production of the hormone calcitonin by the C-cells of the thyroid gland. This condition is often linked to abnormalities in the thyroid, particularly C-cell hyperplasia, which is an increase in the number of these hormone-producing cells. Although calcitonin plays a role in calcium regulation, an overproduction can lead to various health issues and requires careful medical evaluation. This article provides a detailed overview to help understand the causes, symptoms, diagnosis, and potential management of this condition.
Causes & Symptoms
Clinical Causes: C-cell hyperplasia, where the thyroid's C-cells multiply abnormally Medications or conditions that stimulate overproduction of calcitonin Rarely, endocrine tumors such as medullary thyroid carcinoma Genetic predispositions that affect thyroid cell function
Key Symptoms: Often asymptomatic in early stages Neck swelling or a lump in the thyroid region Signs reminiscent of thyroid dysfunction, such as muffled voice or difficulty swallowing Unusual calcium levels, potentially leading to calcium-related symptoms In some cases, symptoms related to underlying tumors or nodules may be present
Diagnostic & Treatment
Diagnosis Path: Diagnosing hypersecretion of calcitonin involves a combination of clinical evaluation and laboratory tests. Blood tests measuring calcitonin levels are central to diagnosis, often revealing abnormally high concentrations. Imaging studies such as ultrasound of the thyroid may identify structural abnormalities like nodules or hyperplasia. In certain cases, biopsy or surgical removal of thyroid tissue may be necessary for definitive diagnosis. Additional tests might include calcium level assessments to evaluate calcium balance and evaluate the impact of the hormone excess.
Treatment Protocols: Treatment strategies depend on the underlying cause and severity. Common approaches include surgical removal of abnormal thyroid tissue or tumors to reduce calcitonin production. In cases where surgery is not feasible, monitoring and managing associated symptoms and complications are essential. Treatments may also involve addressing any underlying thyroid conditions or tumors. Regular follow-up and hormone level monitoring are crucial to assess treatment effectiveness and detect any recurrence or progression.
Clinical Advice & FAQs
Billing Guidance
Is E07.0 a billable ICD-10 code?
Yes, E07.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E07.0?
Clinical documentation must specify the nature of Hypersecretion of calcitonin and any associated comorbidities for accurate reporting.
Cite this Clinical Reference